Summary
Two groups of three male volunteers were exposed to atmospheric concentrations of either 327 or 1833 mg m−3 chlorodifluoromethane (HCFC22) for 4 h. Blood, urine and expired air samples were taken during and after the exposure period and analysed for HCFC22. Urine samples were also analysed for fluoride ion. During the exposure period, blood concentrations of HCFC22 approached a plateau, and the average peak blood concentrations of 0.25 and 1.36 μg cm−3 were proportional to dose. HCFC22 concentrations in expired air were similar to the exposure concentration during the exposure period. The ratio between venous blood and breath concentrations of HCFC22 towards the end of the exposure period was on average 0.77, which is consistent with in vitro estimates of the partition coefficient. In the post-exposure period, three phases for the elimination of HCFC22 were identified, with estimated half-lives of 0.005, 0.2 and 2.6 h. HCFC22 was detected in urine samples taken in the post-exposure period, and the rate of decline was consistent with the terminal rate of elimination estimated from blood and breath measurements. On average 2.1% of the inhaled HCFC22 was recovered in breath within 26 h of exposure. This is consistent with the low solubility in blood and fat. Minimal changes in fluoride ion concentrations in urine following exposure indicate that HCFC22 is unlikely to be metabolised to a significant extent. Following inhalational exposure HCFC22 is poorly absorbed and is rapidly eliminated from the body. Possible biological monitoring strategies could be based on measurements of HCFC22 in urine or breath samples collected after the end of an exposure period.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Anton TR, Woollen BH (1991) A physiologically based pharmacokinetic model for the human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2,-trifluoroethane. Int Arch Occup Environ Health 63:133–138
ECETOC (1989) Joint assessment of commodity chemicals no. 9 chlorodifluoromethane. ECETOC, Brussels
Franks PJ, Hooper RM, Jones PRM, (1989) Solubility of Freon-22 in blood and lung tissue. Br J Anaesth 62:425–428
Health and Safety Executive (1991) Occupational exposure limits. Guidance note EH40/91. HMSO, London
Massmann W (1981) Reference values for the renal excretion of fluoride. J Clin Chem Clin Biochem 19:1039–1041
Peter H, Filser JG, Szentpaly L, Wiegand HJ (1986) Different pharmacokinetics of dichlorofluoromethane (CFC21) and chlorodifluoromethane (CFC22). Arch Toxicol 58:282–283
Sato A, Nakajima T (1979) Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Br J Ind Med 36:231–234
Varene N, Choukroun ML, Martman R, Verene P (1989) Solubility of Freon-22 in human blood and lung tissue. J Appl Physiol 66(5):2468–2471
Wilson HK, Robertson SM, Waldron HA, Gompertz D (1983) Effect of alcohol on the kinetics of mandelic acid excretion on volunteers exposed to styrene vapour. Br J Ind Med 40:75–88
Woollen BH, Guest EA, Howe W, Marsh JR, Wilson HK, Anton TR, Blain PG (1990) Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane. Int Arch Occup Environ Health 62:73–78
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woollen, B.H., Marsh, J.R., Mahler, J.D. et al. Human inhalation pharmacokinetics of chlorodifluoromethane (HCFC22). Int. Arch Occup Environ Heath 64, 383–387 (1992). https://doi.org/10.1007/BF00379550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00379550